Opportunity ID: 263153

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH15-1582
Funding Opportunity Title: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region,
Opportunity Category: Discretionary
Opportunity Category Explanation: –
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: –
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Aug 26, 2014
Last Updated Date: Sep 23, 2014
Original Closing Date for Applications: Oct 06, 2014
Current Closing Date for Applications: Oct 16, 2014
Archive Date: Nov 05, 2014
Estimated Total Program Funding: $4,200,000
Award Ceiling: $4,200,000
Award Floor: –

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants that can apply for this FOA are listed below:
Government Organizations:
•National Ministries of Health
•State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .
•American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
•Political subdivisions of States (in consultation with States)

Non-government Organizations:
•American Indian/Alaska native tribally designated organizations
•Alaska Native health corporations
•Tribal epidemiology centers
•Urban Indian health organizations
•Nonprofit with 501C3 IRS status (other than institution of higher education)
•Nonprofit without 501C3 IRS status (other than institution of higher education)
•Research institutions (that will perform activities deemed as non-research)

Colleges and Universities

Community-based organizations

Faith-based organizations

For-profit organizations (other than small business)

Hospitals

Small, minority, and women-owned businesses

All Other eligible organizations

PEPFAR Local Partner definition:
To be considered eligible as a local partner under this Funding Opportunity Announcement, the applicant must submit supporting documentation demonstrating how their organization meets one of the three criteria listed below under the “PEPFAR Local Partner definition.” The supporting documentation must be included in the Appendices of the application and must be labeled as “Eligibility Documentation for PEPFAR Local Partner Definition.” Applicants that do not provide and/or label the supporting documentation required to meet the PEPFAR Local Partner definition above will not be considered eligible for review.

Under PEPFAR, a “local partner” may be an individual or sole proprietorship, an entity, or a joint venture or other arrangement. However, to be considered a local partner in a given country served by PEPFAR, the partner must meet the criteria under paragraph (1), (2), or (3) below:

(1) an individual must be a citizen or lawfully admitted permanent resident of and have his/her principal place of business in the country served by the PEPFAR program with which the individual is or may become involved, and a sole proprietorship must be owned by such an individual; or

(2) an entity (e.g., a corporation or partnership):
a) must be incorporated or legally organized under the laws of, and have its principal place of business in, the country served by the PEPFAR program with which the entity is or may become involved;
b) must be at 75% for FY 2015 beneficially owned by individuals who are citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), or by other corporations, partnerships or other arrangements that are local partners under this paragraph or paragraph (3);
c) at least 75% for FY 2015 of the entity’s staff (senior, mid-level, support) must be citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), and at least 75% for FY 2015 of the entity’s senior staff (i.e., managerial and professional personnel) must be citizens or lawfully admitted permanent residents of such country; and
d) where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of such country; or

(3) a joint venture, unincorporated association, consortium, or other arrangement in which at least 75% for FY 2015 of the funding under the PEPFAR award is or will be provided to members who are local partners under the criteria in paragraphs (1) or (2) above, and a local partner is designated as the managing member of the organization.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: Swaziland is among the countries with the most severe HIV and TB dual epidemic in the general population. The current annual adult HIV incidence is estimated as high as 2.4%. HIV prevalence among adults aged 18-49 years is 31% and TB incidence rate is 1380/100,000 persons. About 6,000 TB cases are expected to be diagnosed by 2015. Approximately 75-80% of TB cases are co-infected with HIV. HIV prevalence among pregnant women in Swaziland is among the highest globally at 41%. While Swaziland has made significant strides in addressing the HIV and TB dual epidemic, more effort is needed to reach universal coverage at new WHO 2013 recommended guidelines; improve delivery of quality clinical services across the entire continuum of HIV testing, care, treatment and retention such that it is seamless, comprehensive, and integrated within existing structures; and increase capacity for sustainable MOH stewardship at the national, regional, and facility level. Although Swaziland has made great progress in scaling up HIV and TB clinical services, including TB/HIV collaborative activities (Intensified TB case finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Prevention and Control (IPC)), critical gaps and missed opportunities exist in reaching children, adolescents, and key populations (KP) with HIV services, reaching pregnant women and TB clients with ART, efficient utilization of limited resources, and strengthening structures for long term sustainability of quality-assured programs.
Link to Additional Information: –
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Centers for Disease Control and Prevention (CDC)

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

Version History

Version Modification Description Updated Date
Uploaded Amendment I. Sep 23, 2014
Sep 23, 2014

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH15-1582
Funding Opportunity Title: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region,
Opportunity Category: Discretionary
Opportunity Category Explanation: –
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: –
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Aug 26, 2014
Last Updated Date: Sep 23, 2014
Original Closing Date for Applications: Oct 06, 2014
Current Closing Date for Applications: Oct 16, 2014
Archive Date: Nov 05, 2014
Estimated Total Program Funding: $4,200,000
Award Ceiling: $4,200,000
Award Floor: –

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants that can apply for this FOA are listed below:
Government Organizations:
•National Ministries of Health
•State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .
•American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
•Political subdivisions of States (in consultation with States)

Non-government Organizations:
•American Indian/Alaska native tribally designated organizations
•Alaska Native health corporations
•Tribal epidemiology centers
•Urban Indian health organizations
•Nonprofit with 501C3 IRS status (other than institution of higher education)
•Nonprofit without 501C3 IRS status (other than institution of higher education)
•Research institutions (that will perform activities deemed as non-research)

Colleges and Universities

Community-based organizations

Faith-based organizations

For-profit organizations (other than small business)

Hospitals

Small, minority, and women-owned businesses

All Other eligible organizations

PEPFAR Local Partner definition:
To be considered eligible as a local partner under this Funding Opportunity Announcement, the applicant must submit supporting documentation demonstrating how their organization meets one of the three criteria listed below under the “PEPFAR Local Partner definition.” The supporting documentation must be included in the Appendices of the application and must be labeled as “Eligibility Documentation for PEPFAR Local Partner Definition.” Applicants that do not provide and/or label the supporting documentation required to meet the PEPFAR Local Partner definition above will not be considered eligible for review.

Under PEPFAR, a “local partner” may be an individual or sole proprietorship, an entity, or a joint venture or other arrangement. However, to be considered a local partner in a given country served by PEPFAR, the partner must meet the criteria under paragraph (1), (2), or (3) below:

(1) an individual must be a citizen or lawfully admitted permanent resident of and have his/her principal place of business in the country served by the PEPFAR program with which the individual is or may become involved, and a sole proprietorship must be owned by such an individual; or

(2) an entity (e.g., a corporation or partnership):
a) must be incorporated or legally organized under the laws of, and have its principal place of business in, the country served by the PEPFAR program with which the entity is or may become involved;
b) must be at 75% for FY 2015 beneficially owned by individuals who are citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), or by other corporations, partnerships or other arrangements that are local partners under this paragraph or paragraph (3);
c) at least 75% for FY 2015 of the entity’s staff (senior, mid-level, support) must be citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), and at least 75% for FY 2015 of the entity’s senior staff (i.e., managerial and professional personnel) must be citizens or lawfully admitted permanent residents of such country; and
d) where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of such country; or

(3) a joint venture, unincorporated association, consortium, or other arrangement in which at least 75% for FY 2015 of the funding under the PEPFAR award is or will be provided to members who are local partners under the criteria in paragraphs (1) or (2) above, and a local partner is designated as the managing member of the organization.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: Swaziland is among the countries with the most severe HIV and TB dual epidemic in the general population. The current annual adult HIV incidence is estimated as high as 2.4%. HIV prevalence among adults aged 18-49 years is 31% and TB incidence rate is 1380/100,000 persons. About 6,000 TB cases are expected to be diagnosed by 2015. Approximately 75-80% of TB cases are co-infected with HIV. HIV prevalence among pregnant women in Swaziland is among the highest globally at 41%. While Swaziland has made significant strides in addressing the HIV and TB dual epidemic, more effort is needed to reach universal coverage at new WHO 2013 recommended guidelines; improve delivery of quality clinical services across the entire continuum of HIV testing, care, treatment and retention such that it is seamless, comprehensive, and integrated within existing structures; and increase capacity for sustainable MOH stewardship at the national, regional, and facility level. Although Swaziland has made great progress in scaling up HIV and TB clinical services, including TB/HIV collaborative activities (Intensified TB case finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Prevention and Control (IPC)), critical gaps and missed opportunities exist in reaching children, adolescents, and key populations (KP) with HIV services, reaching pregnant women and TB clients with ART, efficient utilization of limited resources, and strengthening structures for long term sustainability of quality-assured programs.
Link to Additional Information: –
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Centers for Disease Control and Prevention (CDC)

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: CDC-RFA-GH15-1582
Funding Opportunity Title: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region,
Opportunity Category: Discretionary
Opportunity Category Explanation: –
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: –
Expected Number of Awards: 1
Assistance Listings: 93.067 — Global AIDS
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 23, 2014
Last Updated Date: –
Original Closing Date for Applications: –
Current Closing Date for Applications: Oct 06, 2014
Archive Date: Nov 05, 2014
Estimated Total Program Funding: $4,200,000
Award Ceiling: $4,200,000
Award Floor: –

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants that can apply for this FOA are listed below:
Government Organizations:
•National Ministries of Health
•State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .
•American Indian/Alaska Native tribal governments (federally recognized or state-recognized)
•Political subdivisions of States (in consultation with States)

Non-government Organizations:
•American Indian/Alaska native tribally designated organizations
•Alaska Native health corporations
•Tribal epidemiology centers
•Urban Indian health organizations
•Nonprofit with 501C3 IRS status (other than institution of higher education)
•Nonprofit without 501C3 IRS status (other than institution of higher education)
•Research institutions (that will perform activities deemed as non-research)

Colleges and Universities

Community-based organizations

Faith-based organizations

For-profit organizations (other than small business)

Hospitals

Small, minority, and women-owned businesses

All Other eligible organizations

PEPFAR Local Partner definition:
To be considered eligible as a local partner under this Funding Opportunity Announcement, the applicant must submit supporting documentation demonstrating how their organization meets one of the three criteria listed below under the “PEPFAR Local Partner definition.” The supporting documentation must be included in the Appendices of the application and must be labeled as “Eligibility Documentation for PEPFAR Local Partner Definition.” Applicants that do not provide and/or label the supporting documentation required to meet the PEPFAR Local Partner definition above will not be considered eligible for review.

Under PEPFAR, a “local partner” may be an individual or sole proprietorship, an entity, or a joint venture or other arrangement. However, to be considered a local partner in a given country served by PEPFAR, the partner must meet the criteria under paragraph (1), (2), or (3) below:

(1) an individual must be a citizen or lawfully admitted permanent resident of and have his/her principal place of business in the country served by the PEPFAR program with which the individual is or may become involved, and a sole proprietorship must be owned by such an individual; or

(2) an entity (e.g., a corporation or partnership):
a) must be incorporated or legally organized under the laws of, and have its principal place of business in, the country served by the PEPFAR program with which the entity is or may become involved;
b) must be at 75% for FY 2015 beneficially owned by individuals who are citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), or by other corporations, partnerships or other arrangements that are local partners under this paragraph or paragraph (3);
c) at least 75% for FY 2015 of the entity’s staff (senior, mid-level, support) must be citizens or lawfully admitted permanent residents of that same country, per sub-paragraph (2)(a), and at least 75% for FY 2015 of the entity’s senior staff (i.e., managerial and professional personnel) must be citizens or lawfully admitted permanent residents of such country; and
d) where an entity has a Board of Directors, at least 51% of the members of the Board must also be citizens or lawfully admitted permanent residents of such country; or

(3) a joint venture, unincorporated association, consortium, or other arrangement in which at least 75% for FY 2015 of the funding under the PEPFAR award is or will be provided to members who are local partners under the criteria in paragraphs (1) or (2) above, and a local partner is designated as the managing member of the organization.

Additional Information

Agency Name: Centers for Disease Control and Prevention
Description: Swaziland is among the countries with the most severe HIV and TB dual epidemic in the general population. The current annual adult HIV incidence is estimated as high as 2.4%. HIV prevalence among adults aged 18-49 years is 31% and TB incidence rate is 1380/100,000 persons. About 6,000 TB cases are expected to be diagnosed by 2015. Approximately 75-80% of TB cases are co-infected with HIV. HIV prevalence among pregnant women in Swaziland is among the highest globally at 41%. While Swaziland has made significant strides in addressing the HIV and TB dual epidemic, more effort is needed to reach universal coverage at new WHO 2013 recommended guidelines; improve delivery of quality clinical services across the entire continuum of HIV testing, care, treatment and retention such that it is seamless, comprehensive, and integrated within existing structures; and increase capacity for sustainable MOH stewardship at the national, regional, and facility level. Although Swaziland has made great progress in scaling up HIV and TB clinical services, including TB/HIV collaborative activities (Intensified TB case finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Prevention and Control (IPC)), critical gaps and missed opportunities exist in reaching children, adolescents, and key populations (KP) with HIV services, reaching pregnant women and TB clients with ART, efficient utilization of limited resources, and strengthening structures for long term sustainability of quality-assured programs.
Link to Additional Information: –
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Centers for Disease Control and Prevention (CDC)

Procurement and Grants Office (PGO)

Technical Information Management Section (TIMS)

Phone: 770-488-2700

Email:pgotim@cdc.gov

Folder 263153 Full Announcement-1 -> 6060-CDC-RFA-GH15-1582 Swaziland REVISED FINAL FOA 8.26.14 A.pdf

Folder 263153 Full Announcement-2 -> GH15-1582 Swaziland FINAL AMEND I 9.23.14.pdf

Packages

Agency Contact Information: Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO)
Technical Information Management Section (TIMS)
Phone: 770-488-2700

Email: pgotim@cdc.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.067 CGH-DGHA-NR Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services in Lubombo Region PKG00204327 Aug 26, 2014 Oct 16, 2014 View

Package 1

Mandatory forms

263153 SF424-2.0.pdf

263153 SF424A-1.0.pdf

263153 HHS_CheckList-1.1.pdf

263153 Project-1.1.pdf

263153 Budget-1.1.pdf

Optional forms

263153 Other-1.1.pdf

2025-07-09T17:06:16-05:00

Share This Post, Choose Your Platform!

XLinkedIn

About the Author: